vs
Side-by-side financial comparison of GUESS INC (GES) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
GUESS INC is the larger business by last-quarter revenue ($791.4M vs $493.8M, roughly 1.6× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 3.2%, a 3.6% gap on every dollar of revenue. On growth, GUESS INC posted the faster year-over-year revenue change (7.2% vs -1.7%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -5.8%).
Guess?, Inc. is an American clothing company, notable for its black-and-white advertisements. It licenses its brand on other fashion accessories, such as watches, jewelry, perfumes, bags and shoes.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
GES vs MD — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $791.4M | $493.8M |
| Net Profit | $25.6M | $33.7M |
| Gross Margin | 42.5% | — |
| Operating Margin | 2.9% | 9.9% |
| Net Margin | 3.2% | 6.8% |
| Revenue YoY | 7.2% | -1.7% |
| Net Profit YoY | 209.6% | 10.5% |
| EPS (diluted) | $0.48 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $791.4M | $493.8M | ||
| Q3 25 | $772.9M | $492.9M | ||
| Q2 25 | $647.8M | $468.8M | ||
| Q1 25 | $932.3M | $458.4M | ||
| Q4 24 | $738.5M | $502.4M | ||
| Q3 24 | $732.6M | $511.2M | ||
| Q2 24 | $591.9M | $504.3M | ||
| Q1 24 | $891.0M | $495.1M |
| Q4 25 | $25.6M | $33.7M | ||
| Q3 25 | $6.2M | $71.7M | ||
| Q2 25 | $-32.9M | $39.3M | ||
| Q1 25 | $81.4M | $20.7M | ||
| Q4 24 | $-23.4M | $30.5M | ||
| Q3 24 | $-10.6M | $19.4M | ||
| Q2 24 | $13.0M | $-153.0M | ||
| Q1 24 | $115.3M | $4.0M |
| Q4 25 | 42.5% | — | ||
| Q3 25 | 42.5% | — | ||
| Q2 25 | 39.9% | — | ||
| Q1 25 | 44.1% | — | ||
| Q4 24 | 43.6% | — | ||
| Q3 24 | 43.7% | — | ||
| Q2 24 | 41.9% | — | ||
| Q1 24 | 45.4% | — |
| Q4 25 | 2.9% | 9.9% | ||
| Q3 25 | 2.3% | 13.8% | ||
| Q2 25 | -5.1% | 12.8% | ||
| Q1 25 | 11.1% | 7.0% | ||
| Q4 24 | 5.7% | 7.8% | ||
| Q3 24 | 6.5% | 6.6% | ||
| Q2 24 | -3.4% | -31.3% | ||
| Q1 24 | 16.3% | 3.2% |
| Q4 25 | 3.2% | 6.8% | ||
| Q3 25 | 0.8% | 14.5% | ||
| Q2 25 | -5.1% | 8.4% | ||
| Q1 25 | 8.7% | 4.5% | ||
| Q4 24 | -3.2% | 6.1% | ||
| Q3 24 | -1.4% | 3.8% | ||
| Q2 24 | 2.2% | -30.3% | ||
| Q1 24 | 12.9% | 0.8% |
| Q4 25 | $0.48 | $0.40 | ||
| Q3 25 | $0.12 | $0.84 | ||
| Q2 25 | $-0.65 | $0.46 | ||
| Q1 25 | $1.29 | $0.24 | ||
| Q4 24 | $-0.47 | $0.37 | ||
| Q3 24 | $-0.28 | $0.23 | ||
| Q2 24 | $0.23 | $-1.84 | ||
| Q1 24 | $1.90 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $154.2M | $375.2M |
| Total DebtLower is stronger | $299.5M | $570.5M |
| Stockholders' EquityBook value | $508.5M | $865.9M |
| Total Assets | $3.0B | $2.2B |
| Debt / EquityLower = less leverage | 0.59× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $154.2M | $375.2M | ||
| Q3 25 | $189.6M | $340.1M | ||
| Q2 25 | $151.2M | $224.7M | ||
| Q1 25 | $187.7M | $99.0M | ||
| Q4 24 | $140.9M | $229.9M | ||
| Q3 24 | $218.9M | $103.8M | ||
| Q2 24 | $241.7M | $19.4M | ||
| Q1 24 | $360.3M | $8.0M |
| Q4 25 | $299.5M | $570.5M | ||
| Q3 25 | $258.4M | $577.2M | ||
| Q2 25 | $241.7M | $583.9M | ||
| Q1 25 | $150.7M | $590.5M | ||
| Q4 24 | $238.3M | $597.1M | ||
| Q3 24 | $187.8M | — | ||
| Q2 24 | $196.9M | — | ||
| Q1 24 | $28.2M | — |
| Q4 25 | $508.5M | $865.9M | ||
| Q3 25 | $487.6M | $890.7M | ||
| Q2 25 | $483.6M | $833.8M | ||
| Q1 25 | $505.0M | $789.2M | ||
| Q4 24 | $450.7M | $764.9M | ||
| Q3 24 | $491.2M | $732.5M | ||
| Q2 24 | $565.5M | $706.5M | ||
| Q1 24 | $684.9M | $856.2M |
| Q4 25 | $3.0B | $2.2B | ||
| Q3 25 | $3.0B | $2.2B | ||
| Q2 25 | $2.9B | $2.1B | ||
| Q1 25 | $2.8B | $2.0B | ||
| Q4 24 | $2.8B | $2.2B | ||
| Q3 24 | $2.8B | $2.1B | ||
| Q2 24 | $2.7B | $2.0B | ||
| Q1 24 | $2.6B | $2.2B |
| Q4 25 | 0.59× | 0.66× | ||
| Q3 25 | 0.53× | 0.65× | ||
| Q2 25 | 0.50× | 0.70× | ||
| Q1 25 | 0.30× | 0.75× | ||
| Q4 24 | 0.53× | 0.78× | ||
| Q3 24 | 0.38× | — | ||
| Q2 24 | 0.35× | — | ||
| Q1 24 | 0.04× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-39.5M | $114.1M |
| Free Cash FlowOCF − Capex | $-56.3M | — |
| FCF MarginFCF / Revenue | -7.1% | — |
| Capex IntensityCapex / Revenue | 2.1% | — |
| Cash ConversionOCF / Net Profit | -1.54× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $62.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-39.5M | $114.1M | ||
| Q3 25 | $74.9M | $137.3M | ||
| Q2 25 | $-73.4M | $137.2M | ||
| Q1 25 | $183.2M | $-117.5M | ||
| Q4 24 | $-83.3M | $133.0M | ||
| Q3 24 | $44.7M | $91.8M | ||
| Q2 24 | $-22.9M | $107.0M | ||
| Q1 24 | $289.5M | $-125.2M |
| Q4 25 | $-56.3M | — | ||
| Q3 25 | $53.4M | — | ||
| Q2 25 | $-95.3M | — | ||
| Q1 25 | $160.7M | — | ||
| Q4 24 | $-105.4M | — | ||
| Q3 24 | $24.3M | — | ||
| Q2 24 | $-44.0M | — | ||
| Q1 24 | $267.8M | — |
| Q4 25 | -7.1% | — | ||
| Q3 25 | 6.9% | — | ||
| Q2 25 | -14.7% | — | ||
| Q1 25 | 17.2% | — | ||
| Q4 24 | -14.3% | — | ||
| Q3 24 | 3.3% | — | ||
| Q2 24 | -7.4% | — | ||
| Q1 24 | 30.1% | — |
| Q4 25 | 2.1% | — | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 3.4% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 3.0% | — | ||
| Q3 24 | 2.8% | — | ||
| Q2 24 | 3.6% | — | ||
| Q1 24 | 2.4% | — |
| Q4 25 | -1.54× | 3.39× | ||
| Q3 25 | 12.00× | 1.91× | ||
| Q2 25 | — | 3.49× | ||
| Q1 25 | 2.25× | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | — | 4.72× | ||
| Q2 24 | -1.76× | — | ||
| Q1 24 | 2.51× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GES
| Products | $760.3M | 96% |
| Royalty | $31.1M | 4% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
